ARA-290 16 MG

ARA-290 is an 11-amino-acid synthetic peptide derived from erythropoietin (EPO), designed to retain tissue-protective and anti-inflammatory properties without stimulating red blood cell production. It is studied for its roles in immune modulation, nerve protection, and chronic inflammatory conditions.

BENEFITS

• Neuroprotection — studied for reducing nerve pain and supporting peripheral neuropathy recovery.
• Anti-inflammatory — explored for calming inflammatory pathways without hematopoietic effects.
• Immune balance — interest in restoring immune homeostasis in chronic conditions.
• Tissue repair — linked to protection in ischemic, cardiac, and renal models.
• Metabolic health — studied for effects in diabetes-related complications.

WHAT RESEARCHERS LOOK AT

• Non-erythropoietic derivative of erythropoietin acting via EPOR/CD131 receptor complex.
• Preclinical and early human trials in neuropathic pain and small fiber neuropathy.
• Exploration in inflammatory, ischemic, and metabolic disease models.
• Potential for tissue-protective effects without stimulating erythropoiesis.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 16 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Sequence: QEQLERALNSS
• Formula / M.W.: C53H83N15O18, ~1178 g/mol
• CAS: 873436-91-0

SELECTED RESEARCH

• PubChem entry — chemical identity:
  
  https://pubchem.ncbi.nlm.nih.gov/compound/ARA-290
  
• Neuropathy and pain reduction clinical trial:
  
  https://pubmed.ncbi.nlm.nih.gov/23473169/
  
• Tissue protection and immune modulation review:
  
  https://pubmed.ncbi.nlm.nih.gov/21912174/
  
• Inflammation and ischemia models:
  
  https://pubmed.ncbi.nlm.nih.gov/22819469/
  

DISCLAIMER

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.